POLYPEPTIDE N revenue breakdown overview

POLYPEPTIDE N revenue for the last year amounted to 316.65 M CHF, the most of which — 165.92 M CHF — came from its highest performing source at the moment, Contract Manufacturing, the year earlier bringing 131.53 M CHF. The greatest contribution to the revenue figure was made by Europe and India — last year it brought POLYPEPTIDE N 230.89 M CHF, and the year before that — 221.14 M CHF.